
About
This AI-powered medical transcription tool converts spoken patient encounters into text and provides instant summaries in various formats. It offers specialized modes for emergencies and customizable templates for efficient charting.
What's New in GenNote
1.0
December 10, 2025
Developer apps
FAQ
What is GenNote?
GenNote is an AI-powered voice recording solution designed for medical professionals. It transcribes patient conversations in real-time and automatically summarizes them into various medical record formats.
How does GenNote handle medical terminology?
GenNote offers specialized 'recording models' for medical terms and 'conversation models' for everyday dialogue. You can also set up custom conversions for frequently used medical terms and abbreviations to ensure accuracy.
Can GenNote be used for emergency situations?
Yes, GenNote provides a dedicated mode for emergency situations like Code Blue (CPCR). This mode allows for accurate voice recording with timestamps using a simple 'press and speak' button.
Does GenNote support different summary formats?
Absolutely. GenNote's AI can analyze recorded conversations and structure them into desired formats such as SOAP, SUB (Subjective), or a concise core summary.
How does GenNote integrate with patient information?
GenNote features a barcode scanning function that allows you to instantly link current patient information to your records, streamlining the documentation process.
What are the security and compliance standards for GenNote?
GenNote adheres to international standards, including ISO27001, ISO27701, and ISO9001. It also complies with domestic personal information protection laws and US HIPAA regulations.
Is GenNote available on multiple devices?
GenNote is currently supported on iPhone and iPad devices, making it accessible for medical professionals on the go.
How often is GenNote updated?
The latest version of GenNote is 1.0, and it was last updated on December 10, 2025. Updates are expected to continue to improve its functionality and reliability.








